BT1718
Phase 1/2Completed 1 views this week 0 watching💤 Quiet
Interest: 22/100
22
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Solid Tumours
Conditions
Advanced Solid Tumours, Non-Small Cell Lung Cancer, Non-Small Cell Lung Sarcoma, Oesophageal Cancer
Trial Timeline
Jan 24, 2018 → Nov 20, 2023
NCT ID
NCT03486730About BT1718
BT1718 is a phase 1/2 stage product being developed by Bicycle Therapeutics for Advanced Solid Tumours. The current trial status is completed. This product is registered under clinical trial identifier NCT03486730. Target conditions include Advanced Solid Tumours, Non-Small Cell Lung Cancer, Non-Small Cell Lung Sarcoma.
What happened to similar drugs?
16 of 20 similar drugs in Advanced Solid Tumours were approved
Approved (16) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
9
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03486730 | Phase 1/2 | Completed |
Competing Products
20 competing products in Advanced Solid Tumours